Supporting a pathogenic contribution for XBP1 mRNA in ALS is the finding that SOD1-ALS mice lacking the XBP-1 gene display reduced mutant SOD1 aggregates and are more resistant to developing ALS-related pathological decline [125]. The gene discussed is XBP1; the disease is amyotrophic lateral sclerosis.